SARATOGA SPRINGS, NY – July 10, 2019 – The Patient Experience Project (PEP), an EVERSANA agency, has announced the addition of Nora Wilder as editorial director. In this role, Wilder will oversee the daily operations of the editorial department and its contribution to quality work. She will be responsible for managing the editorial staff and workflow and implementing department and agency processes.

Wilder brings nearly 20 years of editing and pharmaceutical marketing experience to PEP. She is a proven leader who demonstrates in-depth knowledge across multiple therapeutic areas and brands. Her expertise includes editing, writing, and regulatory guidance for both consumer and professional marketing. She most recently held roles at Syneos Health Communications and Palio.

“Nora’s high editorial standards and deep agency experience ensures that our work is of the highest quality in terms of accuracy, utility, clarity, and readability,” said Christina Vail, managing director of operations at PEP. “She is a valued addition to our team.”

For more information on The Patient Experience Project, visit


About the Patient Experience Project
PEP, an EVERSANA agency, is a full-service, patient-centric marketing and communications firm serving the healthcare, pharmaceutical, and biotechnology industries. PEP has offices in Saratoga Springs, New York, and Chicago, Illinois. PEP’s nationally recognized approach centers around collaboration with the foremost disease experts—patients themselves—to co-create authentic programs and content for patients, caregivers, and healthcare professionals. Learn more about career opportunities at 

EVERSANA is the leading independent provider of global services to the life science industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life science services for a healthier world. To learn more about EVERSANA, visit or connect through LinkedIn and Twitter.